Apitegromab Improves Motor Function in Spinal Muscular Atrophy

MONDAY, Aug. 25, 2025 (HealthDay News) -- For patients with nonambulatory type 2 or type 3 spinal muscular atrophy, apitegromab, a monoclonal antibody that inhi